SHR1020
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SHR1020, covering 2019-01-18 to 2022-11-17. Get the full timeline:
Most recent: Clinical Trial Update: To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma [Phase 2]